This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n7http://linked.opendata.cz/resource/drugbank/drug/DB02135/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB02135/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02135/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02135/identifier/pubchem-substance/

Statements

Subject Item
n2:DB02135
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB02135 n11:DB02135
dcterms:title
4-{2,6,8-Trioxo-9-[(2r,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate
adms:identifier
n7:DB02135 n8:TS1 n12:657028 n13:46506635
n3:IUPAC-Name
n4:271B4119-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B411F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B411E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B411B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B411C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B411D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4117-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4115-363D-11E5-9242-09173F13E4C5 n4:271B4118-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4116-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4125-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4126-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4120-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4121-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4123-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4122-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4124-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B412B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B412D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B412E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B412A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4129-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B412C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B411A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4127-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4128-363D-11E5-9242-09173F13E4C5